Teratogens: a public health issue – a Brazilian overview
Open Access
- 22 May 2017
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 40 (2) , 387-397
Abstract
Congenital anomalies are already the second cause of infant mortality in Brazil, as in many other middle-income countries in Latin America. Birth defects are a result of both genetic and environmental factors, but a multifactorial etiology has been more frequently observed. Here, we address the environmental causes of birth defects – or teratogens – as a public health issue and present their mechanisms of action, categories and their respective maternal-fetal deleterious effects. We also present a survey from 2008 to 2013 of Brazilian cases involving congenital anomalies (annual average of 20,205), fetal deaths (annual average of 1,530), infant hospitalizations (annual average of 82,452), number of deaths of hospitalized infants (annual average of 2,175), and the average cost of hospitalizations (annual cost of $7,758). Moreover, we report on Brazilian cases of teratogenesis due to the recent Zika virus infection, and to the use of misoprostol, thalidomide, alcohol and illicit drugs. Special attention has been given to the Zika virus infection, now proven to be responsible for the microcephaly outbreak in Brazil, with 8,039 cases under investigation (from October 2015 to June 2016). From those cases, 1,616 were confirmed and 324 deaths occurred due to microcephaly complications or alterations on the central nervous system. Congenital anomalies impact life quality and raise costs in specialized care, justifying the classification of teratogens as a public health issue.Keywords
This publication has 84 references indexed in Scilit:
- Substance abuse among individuals with intellectual disabilitiesResearch in Developmental Disabilities, 2012
- Human pre-implantation embryo developmentDevelopment, 2012
- Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in BrazilPLOS ONE, 2011
- Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of DiseaseToxicological Sciences, 2011
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Teratogenic mechanisms of medical drugsHuman Reproduction Update, 2010
- Practice Parameter: Evaluation of the child with microcephaly (an evidence-based review) [RETIRED]Neurology, 2009
- Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicityBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2005
- Detection of human teratogenic agentsThe Journal of Pediatrics, 1982
- Teratogenic agents and congenital malformationsThe Journal of Pediatrics, 1963